1 Day
Source:
AL24 News
Algeria and Germany boost biotech partnership
The Algerian Minister of Pharmaceutical Industry, Waseem Gouaydi, confirmed that the partnership between Algeria and Germany in the pharmaceutical sector has reached a critical stage requiring a shift from traditional manufacturing to knowledge transfer and technological control. The goal is to build sustainable industrial capabilities that enhance health security and open export prospects to African markets. A strategic agreement has been signed between the Sidal Group and Germany's Böhnger Engineering to locally manufacture innovative medicines, including treatments for rare pulmonary fibrosis and breast cancer. This marks a significant step toward solidifying pharmaceutical sovereignty and stimulating national innovation. He explained that government efforts have enabled 82% of the local market needs to be met through domestic production, with fully local manufacturing covering 95% of that figure, positioning Algeria to become a regional export platform.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)